SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044763
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:39
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 842093
2 ex10-1.htm EX-10.1 187588
3 ex31-1.htm EX-31.1 16156
4 ex31-2.htm EX-31.2 16244
5 ex32-1.htm EX-32.1 8228
  Complete submission text file 0001493152-24-044763.txt   4764187

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE brtx-20240930.xsd EX-101.SCH 32173
7 XBRL CALCULATION FILE brtx-20240930_cal.xml EX-101.CAL 45735
8 XBRL DEFINITION FILE brtx-20240930_def.xml EX-101.DEF 142883
9 XBRL LABEL FILE brtx-20240930_lab.xml EX-101.LAB 297898
10 XBRL PRESENTATION FILE brtx-20240930_pre.xml EX-101.PRE 241854
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 672380
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 301341024 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 241448395
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)